Drug intelligence / Profile preview

closantel sodium dihydrate

Development stage
Unknown
Lead developer
Janssen Pharmaceutica
Modality
Small Molecules
Administration
Oral, Subcutaneous, Topical
01

Overview

Closantel sodium dihydrate is a synthetic, halogenated salicylanilide small molecule anthelmintic widely used in veterinary medicine to treat and control parasitic infections in livestock, particularly sheep and cattle. It is highly effective against liver flukes (*Fasciola hepatica* and *Fasciola gigantica*), blood-sucking gastrointestinal nematodes (*Haemonchus contortus*), and certain larval arthropods (such as *Oestrus ovis* and *Hypoderma* species). The drug primarily acts as a proton ionophore, uncoupling mitochondrial oxidative phosphorylation in the parasite, which disrupts ATP synthesis and leads to metabolic depletion and death. It also suppresses the activities of succinate dehydrogenase and fumarate reductase, and has been shown to inhibit chitinase in filarial nematodes. Originally discovered and developed by Janssen Pharmaceutica in the 1970s, closantel sodium dihydrate is administered orally, subcutaneously, or topically.

Brand names
ClosandotClosavirClosecoCuratremExinotFlukiverSeponverSolantelSuflanTriclozVirclosZycloz
Other names
closantelclosantel sodiumclosantel sodium saltclosantelumclosantelum natricum dihydricum
02

Targets

SDH (Mitochondrial electron transport chain complex II)Quinol-fumarate reductase

Beyond the preview

Go deeper on closantel sodium dihydrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on closantel sodium dihydrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call